Literature DB >> 22901590

Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma.

Paul L Crispen1, Aldiana Soljic, Gregory Stewart, Alexander Kutikov, Daniel Davenport, Robert G Uzzo.   

Abstract

PURPOSE: Patients undergoing serial cross-sectional abdominal imaging to evaluate abdominal symptomatology may have a renal tumor develop during followup of an unrelated disease process. Evaluation of such patients provides an opportunity to further define the radiographic inception, natural history and growth patterns of renal tumors.
MATERIALS AND METHODS: Renal tumor databases from 2 institutions were reviewed for patients in whom an enhancing renal tumor developed despite a prior normal cross-sectional radiographic examination of the kidneys. Variables evaluated included age, gender, tumor size at presentation, calculated tumor growth rate from negative scan to radiographic presentation and pathology in patients undergoing definitive treatment.
RESULTS: We identified 36 patients with an average age of 65 years (range 44 to 82). Mean tumor size on presentation was 2.3 cm (range 1.0 to 5.0). The presumed absolute growth rate based on the timing of the initial negative imaging study and tumor diameter at presentation was significantly greater than the observed absolute growth rate after tumor detection (0.71 vs 0.039 cm per year, p = 0.028). No difference was noted between presumed and observed tumor growth based on absolute change in tumor volume (1.44 vs 5.37 cm(3) per year, p = 0.203). Presumed relative growth rates based on tumor diameter (665% vs 23% per year) and volume (1,397% vs 169% per year) were significantly greater than observed relative growth rates (p = 0.005 and p = 0.013, respectively).
CONCLUSIONS: The presumed growth rate of the tumors was significantly greater than the observed growth rate, suggesting that tumor growth rates do not follow a linear pattern throughout their development and progression.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22901590      PMCID: PMC3815634          DOI: 10.1016/j.juro.2012.06.019

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Active surveillance for renal cortical neoplasms.

Authors:  Juan Carlos Rosales; Georgios Haramis; Jorge Moreno; Ketan Badani; Mitchell C Benson; James McKiernan; Cristin Casazza; Jaime Landman
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

2.  Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.

Authors:  Farhang Rabbani; Harry W Herr; Taghreed Almahmeed; Paul Russo
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

3.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

Review 4.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

5.  Enhancing renal masses with zero net growth during active surveillance.

Authors:  David A Kunkle; Paul L Crispen; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

6.  Delayed intervention of sporadic renal masses undergoing active surveillance.

Authors:  Paul L Crispen; Rosalia Viterbo; Eric B Fox; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Cancer       Date:  2008-03-01       Impact factor: 6.860

7.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.

Authors:  Paul L Crispen; Rosalia Viterbo; Stephen A Boorjian; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

8.  The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.

Authors:  Stephen A Boorjian; Paul L Crispen; Christine M Lohse; Bradley C Leibovich; Michael L Blute
Journal:  Eur Urol       Date:  2008-05-09       Impact factor: 20.096

9.  Predicting growth of solid renal masses under active surveillance.

Authors:  Paul L Crispen; Yu-Ning Wong; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Urol Oncol       Date:  2008 Sep-Oct       Impact factor: 3.498

10.  Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.

Authors:  Tobias Klatte; Jean-Jacques Patard; Heiko Wunderlich; Rakhee H Goel; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst P Allhoff; Fairooz F Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre De La Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  2 in total

1.  Mathematical Models for Tumor Growth and the Reduction of Overtreatment.

Authors:  Berdine L Heesterman; John-Melle Bokhorst; Lisa M H de Pont; Berit M Verbist; Jean-Pierre Bayley; Andel G L van der Mey; Eleonora P M Corssmit; Frederik J Hes; Peter Paul G van Benthem; Jeroen C Jansen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-23

2.  Renal functional outcomes after surgery for renal cortical tumors.

Authors:  Danny Lascano; Julia B Finkelstein; G Joel DeCastro; James M McKiernan
Journal:  J Kidney Cancer VHL       Date:  2015-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.